Literature DB >> 19666041

Structural and functional relationships of the steroid hormone receptors' N-terminal transactivation domain.

Raj Kumar1, Gerald Litwack.   

Abstract

Steroid hormone receptors are members of a family of ligand inducible transcription factors, and regulate the transcriptional activation of target genes by recruiting coregulatory proteins to the pre-initiation machinery. The binding of these coregulatory proteins to the steroid hormone receptors is often mediated through their two activation functional domains, AF1, which resides in the N-terminal domain, and the ligand-dependent AF2, which is localized in the C-terminal ligand-binding domain. Compared to other important functional domains of the steroid hormone receptors, our understanding of the mechanisms of action of the AF1 are incomplete, in part, due to the fact that, in solution, AF1 is intrinsically disordered (ID). However, recent studies have shown that AF1 must adopt a functionally active and folded conformation for its optimal activity under physiological conditions. In this review, we summarize and discuss current knowledge regarding the molecular mechanisms of AF1-mediated gene activation, focusing on AF1 conformation and coactivator binding. We further propose models for the binding/folding of the AF1 domains of the steroid hormone receptors and their protein:protein interactions. The population of ID AF1 can be visualized as a collection of many different conformations, some of which may be assuming the proper functional folding for other critical target binding partners that result in the ultimate assembly of AF1:coactivator complexes and subsequent gene regulation. Knowledge of the mechanisms involved therein will significantly help in understanding how signals from a steroid to a specific target gene are conveyed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19666041      PMCID: PMC3074935          DOI: 10.1016/j.steroids.2009.07.012

Source DB:  PubMed          Journal:  Steroids        ISSN: 0039-128X            Impact factor:   2.668


  85 in total

1.  The three-dimensional structures of antagonistic and agonistic forms of the glucocorticoid receptor ligand-binding domain: RU-486 induces a transconformation that leads to active antagonism.

Authors:  Björn Kauppi; Clarissa Jakob; Mathias Färnegårdh; Jie Yang; Harri Ahola; Maria Alarcon; Karin Calles; Owe Engström; John Harlan; Steven Muchmore; Anna-Karin Ramqvist; Susanne Thorell; Lars Ohman; Jonathan Greer; Jan-Ake Gustafsson; Jan Carlstedt-Duke; Mats Carlquist
Journal:  J Biol Chem       Date:  2003-04-09       Impact factor: 5.157

Review 2.  Transactivation functions of the N-terminal domains of nuclear hormone receptors: protein folding and coactivator interactions.

Authors:  Raj Kumar; E Brad Thompson
Journal:  Mol Endocrinol       Date:  2003-01

Review 3.  Unfolding the action of progesterone receptors.

Authors:  Xiaotao Li; Bert W O'Malley
Journal:  J Biol Chem       Date:  2003-07-31       Impact factor: 5.157

4.  TIF2 mediates the synergy between RARalpha 1 activation functions AF-1 and AF-2.

Authors:  Martin Bommer; Arndt Benecke; Hinrich Gronemeyer; Cécile Rochette-Egly
Journal:  J Biol Chem       Date:  2002-07-30       Impact factor: 5.157

Review 5.  Nuclear receptor coregulators: judges, juries, and executioners of cellular regulation.

Authors:  David M Lonard; Bert W O'malley
Journal:  Mol Cell       Date:  2007-09-07       Impact factor: 17.970

6.  Resurrecting the ancestral steroid receptor: ancient origin of estrogen signaling.

Authors:  Joseph W Thornton; Eleanor Need; David Crews
Journal:  Science       Date:  2003-09-19       Impact factor: 47.728

Review 7.  Activation functions 1 and 2 of nuclear receptors: molecular strategies for transcriptional activation.

Authors:  Anette Wärnmark; Eckardt Treuter; Anthony P H Wright; Jan-Ake Gustafsson
Journal:  Mol Endocrinol       Date:  2003-07-31

8.  A novel estrogen receptor alpha-associated protein, template-activating factor Ibeta, inhibits acetylation and transactivation.

Authors:  Margaret A Loven; Nemone Muster; John R Yates; Ann M Nardulli
Journal:  Mol Endocrinol       Date:  2003-01

9.  Effects of different osmolytes on the induced folding of the N-terminal activation domain (AF1) of the glucocorticoid receptor.

Authors:  R Kumar; J M Serrette; S H Khan; A L Miller; E B Thompson
Journal:  Arch Biochem Biophys       Date:  2007-06-29       Impact factor: 4.013

10.  Structural disorder promotes assembly of protein complexes.

Authors:  Hedi Hegyi; Eva Schad; Peter Tompa
Journal:  BMC Struct Biol       Date:  2007-10-08
View more
  15 in total

Review 1.  Allosteric modulators of steroid hormone receptors: structural dynamics and gene regulation.

Authors:  Raj Kumar; Iain J McEwan
Journal:  Endocr Rev       Date:  2012-03-20       Impact factor: 19.871

2.  Binding of the N-terminal region of coactivator TIF2 to the intrinsically disordered AF1 domain of the glucocorticoid receptor is accompanied by conformational reorganizations.

Authors:  Shagufta H Khan; Smita Awasthi; Chunhua Guo; Devrishi Goswami; Jun Ling; Patrick R Griffin; S Stoney Simons; Raj Kumar
Journal:  J Biol Chem       Date:  2012-11-06       Impact factor: 5.157

3.  Intrinsically disordered domains: Sequence ➔ disorder ➔ function relationships.

Authors:  Jianhong Zhou; Christopher J Oldfield; Wenying Yan; Bairong Shen; A Keith Dunker
Journal:  Protein Sci       Date:  2019-08-09       Impact factor: 6.725

Review 4.  Orphan nuclear receptors in breast cancer pathogenesis and therapeutic response.

Authors:  Rebecca B Riggins; Mary M Mazzotta; Omar Z Maniya; Robert Clarke
Journal:  Endocr Relat Cancer       Date:  2010-08-16       Impact factor: 5.678

5.  Transcription factor effector domains.

Authors:  Seth Frietze; Peggy J Farnham
Journal:  Subcell Biochem       Date:  2011

6.  Structural diversity and evolution of the N-terminal isoform-specific region of ecdysone receptor-A and -B1 isoforms in insects.

Authors:  Takayuki Watanabe; Hideaki Takeuchi; Takeo Kubo
Journal:  BMC Evol Biol       Date:  2010-02-12       Impact factor: 3.260

7.  NFAT5, which protects against hypertonicity, is activated by that stress via structuring of its intrinsically disordered domain.

Authors:  Raj Kumar; Jenna F DuMond; Shagufta H Khan; E Brad Thompson; Yi He; Maurice B Burg; Joan D Ferraris
Journal:  Proc Natl Acad Sci U S A       Date:  2020-08-03       Impact factor: 11.205

8.  Thyroid hormone receptor mutations in cancer and resistance to thyroid hormone: perspective and prognosis.

Authors:  Meghan D Rosen; Martin L Privalsky
Journal:  J Thyroid Res       Date:  2011-06-08

9.  An androgen receptor N-terminal domain antagonist for treating prostate cancer.

Authors:  Jae-Kyung Myung; Carmen A Banuelos; Javier Garcia Fernandez; Nasrin R Mawji; Jun Wang; Amy H Tien; Yu Chi Yang; Iran Tavakoli; Simon Haile; Kate Watt; Iain J McEwan; Stephen Plymate; Raymond J Andersen; Marianne D Sadar
Journal:  J Clin Invest       Date:  2013-06-03       Impact factor: 14.808

Review 10.  Role of Steroid Hormones in the Pathogenesis of Nonalcoholic Fatty Liver Disease.

Authors:  Meng Yang; Feng Ma; Min Guan
Journal:  Metabolites       Date:  2021-05-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.